Stem Cell Therapy for Diabetes:

Stem cell therapy holds significant promise for the treatment of diabetes, particularly Type 1 Diabetes (T1D), by offering potential solutions for regenerating insulin-producing beta cells in the pancreas. Researchers are exploring the use of stem cells to create functional beta cells from pluripotent or adult stem cells, which could be transplanted into patients to restore insulin production. Another approach is using stem cells to modulate the immune system, preventing the autoimmune attack that destroys beta cells in T1D. While still in the experimental phase, early studies have shown encouraging results in animal models, and clinical trials are underway to assess the safety and effectiveness of stem cell-based therapies. If successful, this could lead to a more permanent solution for diabetes, reducing the need for lifelong insulin therapy.

    Related Conference of Stem Cell Therapy for Diabetes:

    October 20-21, 2026

    32nd World Diabetes & Heart Congress

    Amsterdam, Netherlands
    October 22-23, 2026

    4th World congress and Expo on Diabetes

    Toronto, Canada
    February 18-19, 2027

    7th International conference on Healthcare Summit

    Singapore City, Singapore
    February 25-26, 2027

    20th International Summit on Diabetes

    London, UK
    March 23-24, 2027

    7th Annual Summit on Diabetes and Endocrinology

    Paris, France
    March 29-30, 2027

    8th Global summit on Diabetes and Endocrinology

    Amsterdam, Netherlands
    June 29-30, 2027

    23rd World Congress on Endocrinology & Diabetes

    Paris, France
    July 08-09, 2027

    35th European Diabetes Congress

    Toronto, Canada
    July 15-16, 2027

    7th International conference on Diabetic complications

    Barcelona, Spain

    Stem Cell Therapy for Diabetes: Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in